Cargando…

Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion

[Image: see text] Techniques enabling in situ monitoring of drug solubilization and changes in the solid-state of the drug during the digestion of milk and milk-based formulations are valuable for predicting the effectiveness of such formulations in improving the oral bioavailability of poorly water...

Descripción completa

Detalles Bibliográficos
Autores principales: Salim, Malinda, Fraser-Miller, Sara J., Be̅rziņš, Ka̅rlis, Sutton, Joshua J., Ramirez, Gisela, Clulow, Andrew J., Hawley, Adrian, Beilles, Stéphane, Gordon, Keith C., Boyd, Ben J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054896/
https://www.ncbi.nlm.nih.gov/pubmed/32011151
http://dx.doi.org/10.1021/acs.molpharmaceut.9b01149
_version_ 1783503269557960704
author Salim, Malinda
Fraser-Miller, Sara J.
Be̅rziņš, Ka̅rlis
Sutton, Joshua J.
Ramirez, Gisela
Clulow, Andrew J.
Hawley, Adrian
Beilles, Stéphane
Gordon, Keith C.
Boyd, Ben J.
author_facet Salim, Malinda
Fraser-Miller, Sara J.
Be̅rziņš, Ka̅rlis
Sutton, Joshua J.
Ramirez, Gisela
Clulow, Andrew J.
Hawley, Adrian
Beilles, Stéphane
Gordon, Keith C.
Boyd, Ben J.
author_sort Salim, Malinda
collection PubMed
description [Image: see text] Techniques enabling in situ monitoring of drug solubilization and changes in the solid-state of the drug during the digestion of milk and milk-based formulations are valuable for predicting the effectiveness of such formulations in improving the oral bioavailability of poorly water-soluble drugs. We have recently reported the use of low-frequency Raman scattering spectroscopy (region of analysis <200 cm(–1)) as an analytical approach to probe solubilization of drugs during digestion in milk using ferroquine (SSR97193) as the model compound. This study investigates the wider utilization of this technique to probe the solubilization behavior of other poorly water-soluble drugs (halofantrine, lumefantrine, and clofazimine) in not only milk but also infant formula in the absence or presence of bile salts during in vitro digestion. Multivariate analysis was used to interpret changes to the spectra related to the drug as a function of digestion time, through tracking changes in the principal component (PC) values characteristic to the drug signals. Characteristic low-frequency Raman bands for all of the drugs were evident after dispersing the solid drugs in suspension form in milk and infant formula. The drugs were generally solubilized during the digestion of the formulations as observed previously for ferroquine and correlated with behavior determined using small-angle X-ray scattering (SAXS). A greater extent of drug solubilization was also generally observed in the infant formula compared to milk. However, in the case of the drug clofazimine, the correlation between low-frequency Raman scattering and SAXS was not clear, which may arise due to background interference from clofazimine being an intense red dye, which highlights a potential limitation of this new approach. Overall, the in situ monitoring of drug solubilization in milk and milk-based formulations during digestion can be achieved using low-frequency Raman scattering spectroscopy, and the information obtained from studying this spectral region can provide better insights into drug solubilization compared to the mid-frequency Raman region.
format Online
Article
Text
id pubmed-7054896
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-70548962020-03-05 Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion Salim, Malinda Fraser-Miller, Sara J. Be̅rziņš, Ka̅rlis Sutton, Joshua J. Ramirez, Gisela Clulow, Andrew J. Hawley, Adrian Beilles, Stéphane Gordon, Keith C. Boyd, Ben J. Mol Pharm [Image: see text] Techniques enabling in situ monitoring of drug solubilization and changes in the solid-state of the drug during the digestion of milk and milk-based formulations are valuable for predicting the effectiveness of such formulations in improving the oral bioavailability of poorly water-soluble drugs. We have recently reported the use of low-frequency Raman scattering spectroscopy (region of analysis <200 cm(–1)) as an analytical approach to probe solubilization of drugs during digestion in milk using ferroquine (SSR97193) as the model compound. This study investigates the wider utilization of this technique to probe the solubilization behavior of other poorly water-soluble drugs (halofantrine, lumefantrine, and clofazimine) in not only milk but also infant formula in the absence or presence of bile salts during in vitro digestion. Multivariate analysis was used to interpret changes to the spectra related to the drug as a function of digestion time, through tracking changes in the principal component (PC) values characteristic to the drug signals. Characteristic low-frequency Raman bands for all of the drugs were evident after dispersing the solid drugs in suspension form in milk and infant formula. The drugs were generally solubilized during the digestion of the formulations as observed previously for ferroquine and correlated with behavior determined using small-angle X-ray scattering (SAXS). A greater extent of drug solubilization was also generally observed in the infant formula compared to milk. However, in the case of the drug clofazimine, the correlation between low-frequency Raman scattering and SAXS was not clear, which may arise due to background interference from clofazimine being an intense red dye, which highlights a potential limitation of this new approach. Overall, the in situ monitoring of drug solubilization in milk and milk-based formulations during digestion can be achieved using low-frequency Raman scattering spectroscopy, and the information obtained from studying this spectral region can provide better insights into drug solubilization compared to the mid-frequency Raman region. American Chemical Society 2020-02-03 2020-03-02 /pmc/articles/PMC7054896/ /pubmed/32011151 http://dx.doi.org/10.1021/acs.molpharmaceut.9b01149 Text en Copyright © 2020 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Salim, Malinda
Fraser-Miller, Sara J.
Be̅rziņš, Ka̅rlis
Sutton, Joshua J.
Ramirez, Gisela
Clulow, Andrew J.
Hawley, Adrian
Beilles, Stéphane
Gordon, Keith C.
Boyd, Ben J.
Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion
title Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion
title_full Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion
title_fullStr Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion
title_full_unstemmed Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion
title_short Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion
title_sort low-frequency raman scattering spectroscopy as an accessible approach to understand drug solubilization in milk-based formulations during digestion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054896/
https://www.ncbi.nlm.nih.gov/pubmed/32011151
http://dx.doi.org/10.1021/acs.molpharmaceut.9b01149
work_keys_str_mv AT salimmalinda lowfrequencyramanscatteringspectroscopyasanaccessibleapproachtounderstanddrugsolubilizationinmilkbasedformulationsduringdigestion
AT frasermillersaraj lowfrequencyramanscatteringspectroscopyasanaccessibleapproachtounderstanddrugsolubilizationinmilkbasedformulationsduringdigestion
AT berzinskarlis lowfrequencyramanscatteringspectroscopyasanaccessibleapproachtounderstanddrugsolubilizationinmilkbasedformulationsduringdigestion
AT suttonjoshuaj lowfrequencyramanscatteringspectroscopyasanaccessibleapproachtounderstanddrugsolubilizationinmilkbasedformulationsduringdigestion
AT ramirezgisela lowfrequencyramanscatteringspectroscopyasanaccessibleapproachtounderstanddrugsolubilizationinmilkbasedformulationsduringdigestion
AT clulowandrewj lowfrequencyramanscatteringspectroscopyasanaccessibleapproachtounderstanddrugsolubilizationinmilkbasedformulationsduringdigestion
AT hawleyadrian lowfrequencyramanscatteringspectroscopyasanaccessibleapproachtounderstanddrugsolubilizationinmilkbasedformulationsduringdigestion
AT beillesstephane lowfrequencyramanscatteringspectroscopyasanaccessibleapproachtounderstanddrugsolubilizationinmilkbasedformulationsduringdigestion
AT gordonkeithc lowfrequencyramanscatteringspectroscopyasanaccessibleapproachtounderstanddrugsolubilizationinmilkbasedformulationsduringdigestion
AT boydbenj lowfrequencyramanscatteringspectroscopyasanaccessibleapproachtounderstanddrugsolubilizationinmilkbasedformulationsduringdigestion